status epilepticus: Status epilepticus is defined as a continuous seizure lasting more than 30 min, or two or more seizures without full recovery of consciousness between any of them.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1410 |
4. Check minimum number of eventsNone |
1410 |
5. Include endpointsNone |
1410 |
6. Filter based on genotype QC (FinnGen only) |
1410 |
Control definitions (FinnGen only)
- Control exclude
- G6_EPIPAROX
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G40-G47
- Name in latin
- Status epilepticus
Similar endpoints
↥List of similar endpoints to
Status epilepticus
based on the number of shared cases.
Similar with more cases:
- Episodal and paroxysmal disorders
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 16312 | 7475 | 8685 |
| Only index persons | 12694 | 6020 | 6674 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.23 | 0.21 | 0.24 |
| Only index persons | 0.24 | 0.22 | 0.25 |
| Median age at first event (years) | |||
| Whole population | 58.08 | 59.36 | 56.83 |
| Only index persons | 58.42 | 59.57 | 57.38 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1410 | 645 | 765 |
| Unadjusted period prevalence (%) | 0.28 | 0.22 | 0.34 |
| Median age at first event (years) | 58.34 | 54.27 | 61.77 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1283
- Matched controls
- 12829
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N03AF02
ATC
oxcarbazepine; oral
134.3
323.0
345
35
N03AG01
ATC
valproic acid; systemic, rectal
43.8
323.0
486
176
G41.9
ICD-10 Finland
Status epilepticus, unspecified
+∞
323.0
738
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
56.9
323.0
489
137
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
+∞
323.0
495
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
9758.2
323.0
573
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
+∞
323.0
825
*
N03AX14
ATC
levetiracetam; systemic
557.3
323.0
527
16
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
+∞
323.0
379
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
323.0
359
*
AA1AD
NOMESCO Finland
CT of head and brain
11.0
302.0
718
1328
G41.0
ICD-10 Finland
Grand mal status epilepticus
+∞
270.6
250
*
N03AX18
ATC
lacosamide; systemic
2641.3
246.9
231
*
183
Kela drug reimbursment
Lamotrigin and topiramate
+∞
241.4
224
*
N03AF01
ATC
carbamazepine; oral, rectal
23.9
203.6
299
161
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
+∞
199.3
186
*
G41.2
ICD-10 Finland
Complex partial status epilepticus
+∞
197.0
184
*
N03AB02
ATC
phenytoin; systemic
119.4
197.0
210
21
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
8.0
182.9
487
915
N05BA09
ATC
clobazam; oral
1835.1
165.2
157
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
6.7
156.9
474
1029
N03AX11
ATC
topiramate; oral
56.9
135.4
160
32
N03AX09
ATC
lamotrigine; oral
16.7
133.1
221
158
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
130.5
123
*
N05BA01
ATC
diazepam; systemic, rectal
6.6
130.5
383
772
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
+∞
124.0
117
*
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
1284.3
121.9
117
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
10.2
120.9
255
303
G40
ICD-10 Finland
Epilepsy
+∞
120.7
114
*
G41.8
ICD-10 Finland
Other status epilepticus
1248.1
118.7
114
*
G40.10
ICD-10 Finland
Simple partial seizures
+∞
103.5
98
*
N88
ICPC
Epilepsy
533.0
101.0
99
*
G41.1
ICD-10 Finland
Petit mal status epilepticus
+∞
100.3
95
*
G40.89
ICD-10 Finland
Other epilepsy
+∞
95.0
90
*
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
6.5
94.1
269
501
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
46.2
92.9
114
27
G47.3
ICD-10 Finland
Sleep apnoea
13.8
88.8
158
129
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
7.8
88.0
217
325
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.7
86.5
494
1863
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
7.8
83.9
207
309
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
+∞
81.1
77
*
3453A
ICD-9 Finland
Epilepsy, Grand mal status
+∞
80.0
76
*
XA800
NOMESCO Finland
Neuropsychological investigation
10.9
79.2
158
163
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
+∞
79.0
75
*
WX730
NOMESCO Finland
Conventional respirator
19.5
77.1
119
67
XA400
NOMESCO Finland
EEG
81.7
75.1
84
11
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
17.3
74.5
120
76
G40.39
ICD-10 Finland
Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures
+∞
69.4
66
*
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
6.0
69.0
205
391
G40.6
ICD-10 Finland
Grand mal seizures, unspecified (with or without petit mal)
+∞
68.3
65
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.0
64.8
510
2319
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
9.2
63.3
138
166
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
8.7
62.4
141
180
TAB00
NOMESCO Finland
Lumbar puncture
9.1
61.2
134
162
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
12.7
60.1
110
94
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
5.7
59.3
185
371
N05CD08
ATC
midazolam; nasal, systemic
11.7
59.3
113
105
N03AE01
ATC
clonazepam; systemic
6.7
58.1
156
258
WX892
NOMESCO Finland
Monitored bed care
5.1
57.5
196
435
R41.0
ICD-10 Finland
Disorientation, unspecified
9.6
56.5
120
137
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
34.1
54.5
71
22
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
19.1
52.6
81
45
N05AH04
ATC
quetiapine; oral
3.4
51.5
288
999
WX872
NOMESCO Finland
Intensive care
6.4
51.4
143
247
R51.80
ICD-10 Finland
Headache
4.1
50.4
215
595
N03AX22
ATC
perampanel; oral
+∞
50.3
48
*
G40.00
ICD-10 Finland
Benign childhood epilepsy with centrotemporal EEG spikes
+∞
49.3
47
*
3451A
ICD-9 Finland
Epilepsy, Generalised convulsive epilepsy
+∞
49.3
47
*
N05AX08
ATC
risperidone; systemic
4.4
48.9
195
505
34599
ICD-8 Finland
Epilepsy, Other and unspecified
+∞
48.2
46
*
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
+∞
48.2
46
*
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
18.0
47.7
75
44
K90
ICPC
Stroke/cerebrovascular accident
11.6
47.3
90
83
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.9
46.2
209
607
F02.89*G40.9
ICD-10 Finland
Dementia in epilepsy
+∞
46.1
44
*
3454A
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]
+∞
46.1
44
*
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
16.6
45.7
74
47
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.1
45.6
286
1071
R53
ICD-10 Finland
Malaise and fatigue
3.0
45.6
320
1294
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
26.6
44.1
61
24
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
4.3
44.0
175
450
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
+∞
44.0
42
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.1
43.8
184
498
N03AX15
ATC
zonisamide; oral
227.5
43.2
44
*
3459X
ICD-9 Finland
Epilepsy, unspecified
+∞
42.9
41
*
A28
ICPC
Limited function/disability NOS
3.1
41.5
260
966
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.6
41.4
209
662
TKC20
NOMESCO Finland
Catheterisation of bladder
4.3
41.2
164
421
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
41.1
330
1441
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
20.6
40.8
61
31
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
+∞
39.8
38
*
F05.9
ICD-10 Finland
Delirium, unspecified
10.2
39.6
80
83
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.3
39.4
227
792
R55
ICD-10 Finland
Syncope and collapse
3.6
39.2
195
608
T90.5
ICD-10 Finland
Sequelae of intracranial injury
17.2
38.4
61
37
XF400
NOMESCO Finland
ECG with 12 standard connections
2.9
38.3
278
1132
N06AB04
ATC
citalopram; systemic
2.7
38.2
309
1346
T36
ICD-10 Finland
Poisoning by systemic antibiotics
5.9
38.1
111
202
N05AH03
ATC
olanzapine; systemic
4.8
38.1
134
303
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
14.0
37.0
64
48
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
12.6
36.5
66
55
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
8.1
35.6
82
107
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.9
35.0
154
431
N03AX23
ATC
brivaracetam; systemic
+∞
34.5
33
*
C03CA01
ATC
furosemide; systemic
2.3
34.4
407
2154
R11
ICD-10 Finland
Nausea and vomiting
3.8
34.1
154
441
A06AD11
ATC
lactulose; oral
2.9
33.9
241
961
W19
ICD-10 Finland
Unspecified fall
3.3
33.7
187
631
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
17.4
33.0
52
31
A86
ICD-10 Finland
Unspecified viral encephalitis
45.8
32.9
40
9
R40.2
ICD-10 Finland
Coma, unspecified
18.3
32.9
51
29
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.9
32.9
226
883
7803A
ICD-9 Finland
General symptoms, Convulsions
19.2
32.9
50
27
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
7.1
32.7
82
122
G44.2
ICD-10 Finland
Tension-type headache
4.4
32.6
125
308
WX704
NOMESCO Finland
Intubation
3.9
32.5
141
389
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
6.4
32.4
88
146
N29
ICPC
Neurological sympt/complt other
10.8
32.4
63
61
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
32.4
550
3399
L01AX03
ATC
temozolomide; systemic
63.4
32.2
37
6
G43.9
ICD-10 Finland
Migraine, unspecified
13.2
31.8
56
44
R42
ICD-10 Finland
Dizziness and giddiness
2.5
31.4
277
1251
G40.51
ICD-10 Finland
Epileptic seizures related to alcohol
+∞
31.4
30
*
N05AA02
ATC
levomepromazine; systemic
5.3
31.1
99
200
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
320.2
31.0
31
*
N05BA04
ATC
oxazepam; oral
2.3
30.9
336
1693
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.4
30.3
114
275
G40.30
ICD-10 Finland
Benign myoclonic eplilepsy in infancy
+∞
30.3
29
*
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
10.3
30.1
60
61
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.7
29.7
140
415
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
10.6
29.6
58
57
34510
ICD-8 Finland
Epilepsy, """"Grand mal""""
+∞
29.3
28
*
N03AG04
ATC
vigabatrin; oral
+∞
28.2
27
*
AA5PD
NOMESCO Finland
CT examination of brain pefusion
25.1
28.0
39
16
S06.0
ICD-10 Finland
Concussion
3.0
27.9
177
652
N06AX11
ATC
mirtazapine; oral
2.1
27.8
394
2221
N05CD07
ATC
temazepam; oral
2.8
27.5
194
765
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
20.1
27.5
41
21
GBB00
NOMESCO Finland
Tracheostomy
12.7
27.4
49
40
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
15.0
27.1
45
31
TPH07
NOMESCO Finland
Cathetrisation of artery
3.0
26.5
169
624
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.5
26.4
130
398
WX882
NOMESCO Finland
High dependency care
5.5
26.4
80
153
R47.0
ICD-10 Finland
Dysphasia and aphasia
17.6
26.3
41
24
L28
ICPC
Limited function/disability (L)
2.5
25.7
224
997
S01.0
ICD-10 Finland
Open wound of scalp
3.1
25.3
148
514
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
13.9
25.1
43
32
F29
ICD-10 Finland
Unspecified nonorganic psychosis
5.1
25.1
82
171
ADB00
NOMESCO Finland
Implantation of vagus nerve stimulating device
+∞
25.1
24
*
R50.9
ICD-10 Finland
Fever, unspecified
2.5
25.0
217
961
AA1BD
NOMESCO Finland
Extensive CT of head and brain
6.7
25.0
65
102
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
5.1
24.8
80
164
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.5
24.8
215
949
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.1
24.8
150
533
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
24.6
284
1452
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.5
24.6
120
365
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
19.0
24.4
37
20
N05CF01
ATC
zopiclone; oral
2.0
24.4
405
2409
G91.0
ICD-10 Finland
Communicating hydrocephalus
29.8
24.1
32
11
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
17.0
24.1
38
23
34532
ICD-8 Finland
Epilepsy, Partialis (focalis) generalisata
+∞
24.0
23
*
AAF00
NOMESCO Finland
Ventriculostomy
26.0
24.0
33
13
G72.8
ICD-10 Finland
Other specified myopathies
8.7
24.0
52
62
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
9.9
23.9
48
50
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
244.2
23.7
24
*
78020
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Convulsions
13.7
23.3
40
30
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
20.5
23.1
34
17
R4120
NOMESCO Finland
Occupational therapy
3.7
23.0
105
302
G40.59
ICD-10 Finland
Other special epileptic syndromes
+∞
23.0
22
*
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
10.3
22.9
45
45
H53.4
ICD-10 Finland
Visual field defects
8.0
22.9
52
67
F10.25
ICD-10 Finland
Alcohol dependence continuous use
7.2
22.9
56
81
F10.20
ICD-10 Finland
Alcohol dependence currently independent
7.0
22.8
57
85
SPAT1234
SPAT
Support of social functional capacity
3.8
22.7
100
279
X59
ICD-10 Finland
Exposure to unspecified factor
2.2
22.6
259
1312
R56.0
ICD-10 Finland
Febrile convulsions
24.4
22.2
31
13
F10.24
ICD-10 Finland
Alcohol depence active use
8.8
22.0
47
55
G40.0
ICD-10 Finland
Localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset
+∞
21.9
21
*
G81.9
ICD-10 Finland
Hemiplegia, unspecified
13.0
21.7
38
30
K91
ICPC
Cerebrovascular disease
16.6
21.5
34
21
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
9.8
21.4
43
45
AAD05
NOMESCO Finland
Evacuation of acute subdural haematoma
23.6
21.3
30
13
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
21.1
21.3
31
15
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
6.6
21.3
55
86
N05AD01
ATC
haloperidol; systemic
4.4
21.0
78
186
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
16.9
21.0
33
20
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.5
20.9
102
310
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.3
20.8
108
344
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.7
20.8
152
609
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
11.1
20.7
39
36
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.7
20.4
91
257
S06.3
ICD-10 Finland
Focal brain injury
7.7
20.2
47
63
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
3.9
19.9
83
221
PA2AD
NOMESCO Finland
CT angiography of brain
36.4
19.9
25
7
SPAT1254
SPAT
Administration of medicine
2.2
19.8
215
1056
G40.3
ICD-10 Finland
Generalized idiopathic epilepsy and epileptic syndromes
+∞
19.8
19
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.3
19.8
208
1005
S06.2
ICD-10 Finland
Diffuse brain injury
11.2
19.7
37
34
R5140
NOMESCO Finland
Monitoring the use of the aid
4.4
19.6
72
170
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
19.6
218
1083
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.5
19.6
163
702
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.7
19.4
146
592
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
12.0
19.3
35
30
F10.09
ICD-10 Finland
Alcohol intoxication UNS
5.9
19.2
54
95
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
19.1
190
893
P15
ICPC
Chronic alcohol abuse
5.3
18.8
58
114
F44.5
ICD-10 Finland
Dissociative convulsions
+∞
18.8
18
*
N03AF04
ATC
eslicarbazepine; oral
+∞
18.8
18
*
N18
ICPC
Paralysis/weakness
7.2
18.7
45
64
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
4.4
18.6
69
165
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.0
18.6
112
397
N07
ICPC
Convulsion/seizure
44.7
18.3
22
5
E87.6
ICD-10 Finland
Hypokalaemia
4.8
18.1
61
132
N07BB01
ATC
disulfiram; oral
3.7
18.1
80
224
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.0
18.1
112
401
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
33.4
18.0
23
7
SPAT1240
SPAT
Therapeutic discussion
2.6
17.8
135
551
SPAT1229
SPAT
Assessment of need for aid
2.8
17.8
120
456
R4150
NOMESCO Finland
Neuropsychological rehabilitation
18.3
17.8
27
15
N19
ICPC
Speech disorder
8.3
17.8
39
48
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
5.1
17.8
56
113
3454B
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[TEMPORAALIEPILEPTINEN POISSAOLOKOHTAUS]
+∞
17.7
17
*
NA1AD
NOMESCO Finland
Cervical spine CT examination
4.0
17.6
72
189
A04
ICPC
Weakness/tiredness general
2.3
17.2
171
803
PA7BD
NOMESCO Finland
CT angiography of neck and brain
9.4
17.2
35
38
N02BE01
ATC
paracetamol; systemic, rectal
1.8
17.1
1004
8570
K92.0
ICD-10 Finland
Haematemesis
5.4
17.1
51
97
G43.3
ICD-10 Finland
Complicated migraine
31.9
17.1
22
7
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
6.2
17.0
46
77
N05BA06
ATC
lorazepam; systemic, sublingual
3.3
16.9
88
282
A41.9
ICD-10 Finland
Sepsis, unspecified
3.9
16.8
69
182
R40.0
ICD-10 Finland
Somnolence
64.2
16.8
19
*
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
64.2
16.8
19
*
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
10.6
16.7
32
31
N03AA02
ATC
phenobarbital; systemic
+∞
16.7
16
*
SPAT1301
SPAT
No procedures
1.8
16.6
381
2470
C71.13
ICD-10 Finland
Malignant tumor of frontal lobe grade IV glioma
172.1
16.5
17
*
N99
ICPC
Neurological disease other
8.7
16.5
35
41
N30.9
ICD-10 Finland
Cystitis, unspecified
3.3
16.5
85
270
F10.41
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol with seizures
40.6
16.4
20
5
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
40.6
16.4
20
5
SPAT1216
SPAT
Assessment of functional ability
2.1
16.1
200
1035
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
30.4
16.1
21
7
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.9
16.0
102
374
N03AX12
ATC
gabapentin; oral
2.2
16.0
176
864
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
16.0
205
1079
N03AX16
ATC
pregabalin; oral
1.9
15.9
259
1492
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
12.4
15.9
28
23
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
7.7
15.7
36
48
N30.0
ICD-10 Finland
Acute cystitis
2.2
15.6
163
783
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
15.6
390
2592
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
38.5
15.4
19
5
A02BC02
ATC
pantoprazole; systemic
1.6
15.2
714
5617
I60.1
ICD-10 Finland
Subarachnoid haemorrhage from middle cerebral artery
18.0
15.2
23
13
G91.1
ICD-10 Finland
Obstructive hydrocephalus
20.3
15.1
22
11
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
45.5
15.1
18
*
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
8.2
15.1
33
41
N05AB03
ATC
perphenazine; systemic, rectal
3.9
15.0
62
165
181
Kela drug reimbursment
Retigabine and vigabatrin
+∞
14.6
14
*
3452A
ICD-9 Finland
Epilepsy, Petit mal status
+∞
14.6
14
*
N05AX12
ATC
aripiprazole; systemic
3.9
14.5
59
155
P99
ICPC
Psychological disorders other
4.7
14.4
49
108
N28
ICPC
Limited function/disability (N)
7.0
14.4
35
51
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
14.4
319
2034
F05.8
ICD-10 Finland
Other delirium
12.7
14.4
25
20
A46
ICD-10 Finland
Erysipelas
2.1
14.2
174
894
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
5.0
14.1
45
93
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
7.6
14.0
32
43
J01DB01
ATC
cefalexin; oral
1.6
13.9
953
8167
R06.0
ICD-10 Finland
Dyspnoea
1.8
13.8
262
1585
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
4.9
13.8
45
95
SPAT1262
SPAT
Handing over of treatment supplies
1.9
13.7
209
1174
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
6.0
13.7
37
63
D21
ICPC
Swallowing problem
7.3
13.6
32
45
N05AF03
ATC
chlorprothixene; systemic
4.1
13.5
52
130
B01AA03
ATC
warfarin; systemic
1.8
13.5
248
1483
X58
ICD-10 Finland
Exposure to other specified factors
2.1
13.5
166
856
G93.4
ICD-10 Finland
Encephalopathy, unspecified
34.4
13.5
17
5
E86
ICD-10 Finland
Volume depletion
4.4
13.4
48
112
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
13.0
13.4
23
18
R4130
NOMESCO Finland
Speech therapy
5.2
13.4
41
81
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.4
13.4
66
204
F60.9
ICD-10 Finland
Personality disorder, unspecified
8.2
13.3
29
36
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.9
13.3
55
147
R4110
NOMESCO Finland
Physiotherapy
1.7
13.3
306
1966
WX725
NOMESCO Finland
Noninvasive ventilation
3.3
13.2
66
206
XX3DW
NOMESCO Finland
Time consuming IT work
2.3
13.2
125
573
N06AX16
ATC
venlafaxine; oral
2.2
13.1
143
697
D64.9
ICD-10 Finland
Anaemia, unspecified
2.2
13.1
139
672
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.8
13.1
84
309
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
4.1
13.0
50
125
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
8.9
13.0
27
31
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
6.7
12.8
32
49
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
11.7
12.8
23
20
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.6
12.8
94
376
N02AA05
ATC
oxycodone; systemic
2.0
12.8
176
950
A98
ICPC
Health maint/preventive medicine
0.6
12.6
974
10804
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
70.5
12.6
14
*
R13
ICD-10 Finland
Dysphagia
2.8
12.6
82
306
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
32.4
12.6
16
5
J01CA08
ATC
pivmecillinam; oral
1.6
12.6
381
2640
G40.50
ICD-10 Finland
Epilepsia partialis continua [Kozhevnikof]
+∞
12.5
12
*
34520
ICD-8 Finland
Epilepsy, Status epilepticus
+∞
12.5
12
*
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
+∞
12.5
12
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
12.5
228
1356
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
24.6
12.5
17
7
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
5.3
12.5
37
71
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.7
12.4
84
321
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
37.9
12.2
15
*
R25.2
ICD-10 Finland
Cramp and spasm
5.2
12.2
37
73
A03FA01
ATC
metoclopramide; systemic, rectal
1.8
12.1
223
1333
JN3AD
NOMESCO Finland
Abdominal CT examination
2.5
12.1
93
383
R46.8
ICD-10 Finland
Other symptoms and signs involving appearance and behaviour
47.1
11.9
14
*
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
11.8
11.8
21
18
C07AB07
ATC
bisoprolol; oral
1.5
11.8
507
3818
R51
ICD-10 Finland
Headache
3.4
11.8
57
174
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
11.8
195
1121
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.7
11.8
309
2053
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.5
11.7
94
396
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
4.3
11.7
42
99
N05CD02
ATC
nitrazepam; oral
4.8
11.7
38
81
M03BX01
ATC
baclofen; systemic
6.1
11.7
31
52
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
7.0
11.6
28
41
C71.23
ICD-10 Finland
Malignant tumor of temporal lobe grade IV glioma
65.5
11.6
13
*
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
19.1
11.6
17
9
WX890
NOMESCO Finland
Intesive care monitoring
8.2
11.6
25
31
EBA15
NOMESCO Finland
Extraction of large number of teeth
3.1
11.6
64
216
C07AB02
ATC
metoprolol; systemic
1.7
11.5
239
1484
34530
ICD-8 Finland
Epilepsy, Psychomotorica
+∞
11.5
11
*
N03AD01
ATC
ethosuximide; oral
+∞
11.5
11
*
N03AG06
ATC
tiagabine; oral
+∞
11.5
11
*
R1260
NOMESCO Finland
Evaluation of communicative skills
5.4
11.4
33
62
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
15.2
11.3
18
12
N05BA02
ATC
chlordiazepoxide; systemic
4.2
11.3
42
103
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
11.2
334
2291
N06AA09
ATC
amitriptyline; systemic
2.3
11.2
107
492
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
11.1
296
1968
N06AB10
ATC
escitalopram; oral
1.8
11.1
201
1192
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.6
11.0
81
326
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
9.3
11.0
22
24
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
7.5
11.0
25
34
S06.6
ICD-10 Finland
Traumatic subarachnoid haemorrhage
7.5
11.0
25
34
S72.0
ICD-10 Finland
Fracture of neck of femur
3.0
11.0
64
224
R60.0
ICD-10 Finland
Localized oedema
2.1
10.9
126
631
P29
ICPC
Psychological sympt/compl other
2.8
10.8
71
267
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
6.2
10.8
28
46
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
5.4
10.8
31
58
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
28.3
10.7
14
5
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
7.6
10.7
24
32
Y86
ICD-10 Finland
Sequelae of other accidents
13.0
10.7
18
14
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
5.6
10.6
30
55
N06AB03
ATC
fluoxetine; oral
2.0
10.6
136
712
F83
ICD-10 Finland
Mixed specific developmental disorders
8.6
10.5
22
26
F43.1
ICD-10 Finland
Post-traumatic stress disorder
4.6
10.5
35
77
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.4
10.5
50
152
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.2
10.5
54
174
F32.8
ICD-10 Finland
Other depressive episodes
6.2
10.5
27
44
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.5
10.5
36
82
G81.1
ICD-10 Finland
Spastic hemiplegia
110.8
10.4
11
*
G41
ICD-10 Finland
Status epilepticus
+∞
10.4
10
*
3450A
ICD-9 Finland
Epilepsy, Generalised nonconvulsive epilepsy
+∞
10.4
10
*
Z02.4
ICD-10 Finland
Examination for driving licence
0.5
10.4
102
1825
R25.1
ICD-10 Finland
Tremor, unspecified
3.6
10.4
45
127
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
5.4
10.3
30
57
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.2
10.3
38
93
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
10.3
158
884
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
23.6
10.2
14
6
F79.9
ICD-10 Finland
Unspecified mental retardation, without mention of impairment of behaviour
23.6
10.2
14
6
S42.2
ICD-10 Finland
Fracture of upper end of humerus
3.0
10.2
58
197
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
4.0
10.2
39
99
K59.0
ICD-10 Finland
Constipation
2.7
10.0
70
272
N06AB06
ATC
sertraline; oral
2.1
10.0
115
575
I50.9
ICD-10 Finland
Heart failure, unspecified
1.9
9.9
158
897
F34.1
ICD-10 Finland
Dysthymia
3.8
9.9
41
111
SPAT1263
SPAT
Sampling
1.5
9.9
460
3487
J01MA02
ATC
ciprofloxacin; systemic
1.5
9.9
425
3169
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
5.3
9.9
29
56
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.3
9.8
48
149
F10.73
ICD-10 Finland
Residual or late-onset psychosis caused by alcohol dementia
20.2
9.8
14
7
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
4.9
9.8
31
65
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.4
9.8
46
139
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
3.1
9.7
51
167
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.9
9.7
57
201
N06AX21
ATC
duloxetine; oral
2.2
9.7
99
470
N05AH02
ATC
clozapine; systemic
4.1
9.7
36
89
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.6
9.7
68
266
S02.00
ICD-10 Finland
Fracture of the upper part of the head closed
11.5
9.6
17
15
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
9.6
338
2405
J01DA01
ATC
[U] cefalexin; systemic
1.4
9.5
691
5722
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
10.1
9.5
18
18
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
9.5
191
1167
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.9
9.5
56
199
S00.1
ICD-10 Finland
Contusion of eyelid and periocular area
4.4
9.4
33
77
C71.21
ICD-10 Finland
Malignant tumor of temporal lobe grade II glioma
100.7
9.4
10
*
2910A
ICD-9 Finland
Alcoholic psychoses, Alcohol withdrawal delirium
100.7
9.4
10
*
G40.7
ICD-10 Finland
Petit mal, unspecified, without grand mal seizures
100.7
9.4
10
*
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
100.7
9.4
10
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
9.4
90
416
G40.8
ICD-10 Finland
Other epilepsy
+∞
9.4
9
*
G40.80
ICD-10 Finland
Epilepsy with continuous EEG spike-waves during slow wave sleep
+∞
9.4
9
*
3454X
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[ALII DISTURBATIONES CONSCIENTAE EPILEPTICI]
+∞
9.4
9
*
C71.1
ICD-10 Finland
Malignant neoplasm: Frontal lobe
+∞
9.4
9
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
8.1
9.3
20
25
S42.0
ICD-10 Finland
Fracture of clavicle
3.3
9.3
45
139
Z03
ICPC
Housing/neighbourhood problem
8.7
9.3
19
22
XCK00
NOMESCO Finland
Perimetry
2.4
9.3
81
356
N05AN01
ATC
lithium; oral
3.9
9.3
37
98
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
5.3
9.2
27
52
J01EA01
ATC
trimethoprim; systemic
1.6
9.2
250
1668
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.3
9.1
88
406
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
11.5
9.1
16
14
N04AA02
ATC
biperiden; systemic
3.8
9.1
37
100
AAK00
NOMESCO Finland
Cranioplasty
36.9
9.0
11
*
A02BC01
ATC
omeprazole; systemic
1.6
9.0
306
2155
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
4.9
9.0
28
58
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
3.2
9.0
45
143
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
5.3
8.9
26
50
H03AA01
ATC
levothyroxine sodium; systemic
1.6
8.9
224
1461
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
3.1
8.9
46
150
F41.8
ICD-10 Finland
Other specified anxiety disorders
4.5
8.9
30
68
S22.3
ICD-10 Finland
Fracture of rib
2.3
8.8
82
375
K59.09
ICD-10 Finland
Constipation, unspecified
2.5
8.8
70
295
A10AE04
ATC
insulin glargine; parenteral
2.1
8.8
104
525
G93.1
ICD-10 Finland
Anoxic brain damage, not elsewhere classified
10.8
8.8
16
15
R41.3
ICD-10 Finland
Other amnesia
3.7
8.8
37
103
ZXC95
NOMESCO Finland
Use of surgical navigator
6.0
8.8
23
39
I46.0
ICD-10 Finland
Cardiac arrest with successful resuscitation
4.5
8.7
29
65
WX780
NOMESCO Finland
Remote monitoring CPAP
50.3
8.7
10
*
AAA27
NOMESCO Finland
Insertion of intracerebral pressure monitoring device
50.3
8.7
10
*
Z43.0
ICD-10 Finland
Attention to tracheostomy
50.3
8.7
10
*
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.0
8.6
115
609
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
6.2
8.6
22
36
H02AB02
ATC
dexamethasone; systemic
2.0
8.6
117
626
C08CA01
ATC
amlodipine; oral
1.5
8.6
373
2769
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
8.6
599
4885
F20.9
ICD-10 Finland
Schizophrenia, unspecified
3.6
8.6
37
105
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
4.1
8.6
32
80
F43.29
ICD-10 Finland
Adaptation disorder UNS
4.8
8.6
27
57
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
16.4
8.6
13
8
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
7.0
8.6
20
29
F10.03
ICD-10 Finland
Alcohol-related acute intoxication with delirium
10.1
8.5
16
16
5CM18
NOMESCO Finland
NA
10.1
8.5
16
16
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.1
8.5
93
455
K56.0
ICD-10 Finland
Paralytic ileus
6.4
8.5
21
33
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
6.4
8.5
21
33
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
27.7
8.5
11
*
S01.9
ICD-10 Finland
Open wound of head, part unspecified
3.8
8.5
34
91
Z00.0
ICD-10 Finland
General medical examination
1.7
8.4
191
1210
G91.8
ICD-10 Finland
Other hydrocephalus
90.6
8.4
9
*
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.1
8.4
91
446
PA2AC
NOMESCO Finland
Cerebral angiography with X-ray
12.8
8.4
14
11
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
3.9
8.4
33
87
AAJ20
NOMESCO Finland
Excision of epileptic focus
+∞
8.3
8
*
G40.36
ICD-10 Finland
Juvenile myoclonic epilepsy [impulsive petit mal]
+∞
8.3
8
*
3472A
ICD-9 Finland
Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]
+∞
8.3
8
*
34519
ICD-8 Finland
Epilepsy, Generalisata convulsiva NUD
+∞
8.3
8
*
F71.0
ICD-10 Finland
Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour
+∞
8.3
8
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.9
8.3
115
620
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
8.6
8.3
17
20
P76
ICPC
Depressive disorder
2.5
8.3
63
259
RS222
NOMESCO Finland
NA
4.8
8.3
26
55
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.7
8.2
53
199
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
8.2
131
741
OAB43
SPAT
NA
0.4
8.2
45
975
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.9
8.2
118
647
WX002
NOMESCO Finland
Sedation and analgesia
1.6
8.2
203
1316
WX722
NOMESCO Finland
PEEP
4.4
8.1
28
65
H02AB09
ATC
hydrocortisone; systemic
3.5
8.1
36
105
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.3
8.1
76
348
C71.30
ICD-10 Finland
Malignant tumor in parietal lobe without histology
33.5
8.1
10
*
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.6
8.1
57
227
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
8.0
109
584
F61.0
ICD-10 Finland
Mixed personality disorders
4.3
8.0
28
66
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.2
8.0
81
385
F06.8
ICD-10 Finland
Other specified mental disorders due to brain damage and dysfunction and to physical disease
22.2
8.0
11
5
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.2
8.0
78
363
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
7.3
8.0
18
25
H53.2
ICD-10 Finland
Diplopia
3.2
8.0
39
123
XF600
NOMESCO Finland
Bloodpressure measurement
2.2
7.9
80
379
C07AA05
ATC
propranolol; systemic
1.7
7.9
186
1189
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.6
7.9
234
1585
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
5.0
7.9
24
49
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
4.1
7.9
29
72
N05AD03
ATC
melperone; systemic
4.6
7.9
26
58
7840A
ICD-9 Finland
Symptoms involving head and neck, Headache
7.8
7.9
17
22
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
5.4
7.8
22
41
EBA00
NOMESCO Finland
Extraction of tooth
1.5
7.8
355
2651
Z72.1
ICD-10 Finland
Alcohol use
4.7
7.8
25
54
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
7.8
169
1055
H47.2
ICD-10 Finland
Optic atrophy
9.5
7.8
15
16
J15.8
ICD-10 Finland
Other bacterial pneumonia
7.0
7.8
18
26
N05BA12
ATC
alprazolam; oral
2.0
7.8
103
548
N05BE01
ATC
buspirone; oral
3.1
7.8
40
131
WX110
NOMESCO Finland
Local anesthesy
1.4
7.7
742
6356
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
15.1
7.7
12
8
RS122
NOMESCO Finland
NA
15.1
7.7
12
8
C71.2
ICD-10 Finland
Malignant neoplasm: Temporal lobe
45.2
7.7
9
*
WX723
NOMESCO Finland
CPAP therapy
45.2
7.7
9
*
F80.1
ICD-10 Finland
Expressive language disorder
6.0
7.7
20
34
H50.31
ICD-10 Finland
Intermittent exotropia
7.5
7.7
17
23
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.0
7.7
90
457
SPAT1251
SPAT
Organisation of medication
2.8
7.7
47
173
UJD02
NOMESCO Finland
Gastroscopy
2.5
7.6
57
235
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.2
7.6
73
339
F41.09
ICD-10 Finland
UNS Panic Syndrome
3.6
7.6
32
90
N80
ICPC
Head injury other
3.9
7.6
29
75
9440/3-C71.9
ICD-O-3
Glioblastoma, NOS, of brain, NOS
25.2
7.6
10
*
F10.06
ICD-10 Finland
Alcohol-related acute intoxication with seizures
25.2
7.6
10
*
AAF15
NOMESCO Finland
Ventriculoatrial shunt
25.2
7.6
10
*
S97
ICPC
Chronic ulcer skin
2.3
7.6
68
307
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
5.2
7.6
22
43
R20.2
ICD-10 Finland
Paraesthesia of skin
2.4
7.6
62
267
P01
ICPC
Feeling anxious/nervous/tense
1.9
7.5
103
553
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
4.7
7.5
24
52
SPAT1172
SPAT
Guidance concerning hydration
3.3
7.5
35
107
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
7.2
7.5
17
24
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
4.0
7.5
28
71
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.9
7.4
43
151
G44.1
ICD-10 Finland
Vascular headache, not elsewhere classified
80.5
7.4
8
*
R47.1
ICD-10 Finland
Dysarthria and anarthria
6.5
7.4
18
28
N06AB05
ATC
paroxetine; oral
2.4
7.4
61
263
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
7.7
7.4
16
21
P72
ICPC
Schizophrenia
3.6
7.4
31
87
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
13.4
7.4
12
9
J01FF01
ATC
clindamycin; systemic
1.5
7.4
281
2021
A12BA01
ATC
potassium chloride; oral
2.5
7.3
55
227
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
2.8
7.3
44
160
C03DA01
ATC
spironolactone; oral
1.9
7.3
111
621
F40.9
ICD-10 Finland
Phobic anxiety disorder, unspecified
10.9
7.3
13
12
K70.4
ICD-10 Finland
Alcoholic hepatic failure
10.9
7.3
13
12
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
6.9
7.3
17
25
C71.29
ICD-10 Finland
Malignant tumor in temporal lobe other or unspecified histology
+∞
7.3
7
*
1287
NOMESCO Finland
NA
+∞
7.3
7
*
6280
NOMESCO Finland
NA
+∞
7.3
7
*
R06.4
ICD-10 Finland
Hyperventilation
5.0
7.3
22
45
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
7.3
268
1913
L89
ICD-10 Finland
Decubitus ulcer and pressure area
3.8
7.3
29
78
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
5.2
7.3
21
41
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
6.3
7.2
18
29
205
Kela drug reimbursment
Chronic hypertension
1.5
7.2
296
2158
Z75.5
ICD-10 Finland
Holiday relief care
5.5
7.2
20
37
G43.8
ICD-10 Finland
Other migraine
15.8
7.2
11
7
AA1AA
NOMESCO Finland
Head X-ray examination
5.8
7.2
19
33
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
2.9
7.1
41
143
AAD15
NOMESCO Finland
Evacuation of traumatic intracerebral haematoma
30.2
7.1
9
*
C71.11
ICD-10 Finland
Malignant tumor of frontal lobe grade II glioma
30.2
7.1
9
*
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.7
7.1
139
842
U04
ICPC
Incontinence urine
2.5
7.1
53
217
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
4.2
7.1
25
60
F22.0
ICD-10 Finland
Delusional disorder
4.6
7.1
23
51
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.9
7.1
103
565
I63.8
ICD-10 Finland
Other cerebral infarction
6.1
7.1
18
30
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
5.7
7.1
19
34
H50.1
ICD-10 Finland
Divergent concomitant strabismus
8.8
7.1
14
16
C02AC05
ATC
moxonidine; oral
2.5
7.0
52
211
J96.0
ICD-10 Finland
Acute respiratory failure
4.2
7.0
25
61
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
4.2
7.0
25
61
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.2
7.0
71
337
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
7.0
7.0
16
23
N06AX26
ATC
vortioxetine; oral
2.4
7.0
55
231
E66.9
ICD-10 Finland
Obesity, unspecified
3.4
6.9
31
92
PA2VT
NOMESCO Finland
Intravascular evacuation of brain artery embolus
13.8
6.9
11
8
S02.11
ICD-10 Finland
Fracture of base of skull, open
13.8
6.9
11
8
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.4
6.9
53
223
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.9
6.9
102
567
N05AC02
ATC
thioridazine; oral
3.4
6.9
31
93
J46
ICD-10 Finland
Status asthmaticus
3.4
6.9
31
93
SPAT1231
SPAT
Assessment of adjustments needed in living environment
3.5
6.8
29
83
ZX122
NOMESCO Finland
Intra-arterial
11.0
6.8
12
11
S43.0
ICD-10 Finland
Dislocation of shoulder joint
2.6
6.8
45
174
T68
ICD-10 Finland
Hypothermia
9.4
6.8
13
14
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.7
6.8
139
855
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
5.7
6.8
18
32
J01MA12
ATC
levofloxacin; systemic
1.6
6.8
202
1373
G45.3
ICD-10 Finland
Amaurosis fugax
40.2
6.8
8
*
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.5
6.7
49
200
K08.3
ICD-10 Finland
Retained dental root
2.0
6.7
81
416
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
16.8
6.7
10
6
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.3
6.7
23
54
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.3
6.7
31
95
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
22.6
6.7
9
*
5AB01
NOMESCO Finland
NA
22.6
6.7
9
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.9
6.7
92
495
Y0209
ICD-8 Finland
Examination of the nervous system and sensory organs, Nervous system
6.5
6.6
16
25
S82.8
ICD-10 Finland
Fractures of other parts of lower leg
2.8
6.6
39
140
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.7
6.6
134
820
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
5.5
6.6
18
33
L76
ICPC
Fracture: other
3.1
6.6
33
107
RT150
NOMESCO Finland
NA
12.3
6.6
11
9
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
12.3
6.6
11
9
E66.01
ICD-10 Finland
Obesity due to excess calories
2.3
6.6
56
248
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
8.7
6.6
13
15
JDB10
NOMESCO Finland
Percutaneous gastrostomy
4.4
6.5
22
51
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.8
6.5
39
142
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
6.9
6.5
15
22
R06.5
ICD-10 Finland
Mouth breathing
2.3
6.5
56
250
S09.9
ICD-10 Finland
Unspecified injury of head
4.5
6.5
21
47
N05AF05
ATC
zuclopenthixol; systemic
4.5
6.5
21
47
C71.33
ICD-10 Finland
Malignant tumor of parietal lobe grade IV glioma
70.2
6.4
7
*
9440/3-C71.2
ICD-O-3
Glioblastoma, NOS, of temporal lobe
70.2
6.4
7
*
G06.0
ICD-10 Finland
Intracranial abscess and granuloma
70.2
6.4
7
*
AAA10
NOMESCO Finland
Biopsy through craniotomy
70.2
6.4
7
*
Z02.7
ICD-10 Finland
Issue of medical certificate
2.1
6.4
72
360
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.1
6.4
32
104
RS221
NOMESCO Finland
NA
4.1
6.4
23
57
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
4.1
6.4
23
57
F06.9
ICD-10 Finland
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
14.4
6.4
10
7
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.9
6.4
90
491
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
6.4
146
927
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.8
6.3
99
560
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
2.2
6.3
60
280
SPAT1210
SPAT
Application of cast or individual aid
2.6
6.3
43
170
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
6.0
6.3
16
27
P80
ICPC
Personality disorder
11.1
6.3
11
10
N05AA01
ATC
chlorpromazine; systemic, rectal
4.0
6.3
23
58
SPAT1260
SPAT
Consultation of another employee
1.6
6.3
177
1186
R03DA04
ATC
theophylline; systemic, rectal
2.2
6.3
62
294
K70.9
ICD-10 Finland
Alcoholic liver disease, unspecified
9.3
6.3
12
13
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
18.1
6.3
9
5
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
18.1
6.3
9
5
113
Kela drug reimbursment
Anxiety disorders associated with mental retardation
18.1
6.3
9
5
A08.1
ICD-10 Finland
Acute gastroenteropathy due to Norovirus
18.1
6.3
9
5
E66.8
ICD-10 Finland
Other obesity
2.8
6.3
37
134
X57
ICD-10 Finland
Unspecified privation
3.1
6.3
32
106
G05.1*B00.4
ICD-10 Finland
Herpesviral meningoencephalitis
+∞
6.3
6
*
G93.6
ICD-10 Finland
Cerebral oedema
+∞
6.3
6
*
G43.2
ICD-10 Finland
Status migrainosus
+∞
6.3
6
*
34500
ICD-8 Finland
Epilepsy, """"Petit mal""""
+∞
6.3
6
*
34598
ICD-8 Finland
Epilepsy, Alia definita
+∞
6.3
6
*
G40.33
ICD-10 Finland
Juvenile absence epilepsy
+∞
6.3
6
*
3460A
ICD-9 Finland
Migraine, Classical migraine
+∞
6.3
6
*
N03AX17
ATC
stiripentol; oral
+∞
6.3
6
*
9440/3-C71.1
ICD-O-3
Glioblastoma, NOS, of frontal lobe
+∞
6.3
6
*
34609
ICD-8 Finland
Migraine, Unspecified
+∞
6.3
6
*
B94.1
ICD-10 Finland
Sequelae of viral encephalitis
+∞
6.3
6
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.3
6.2
54
241
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.9
6.2
89
488
F07.9
ICD-10 Finland
Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction
26.8
6.2
8
*
S06.8
ICD-10 Finland
Other intracranial injuries
26.8
6.2
8
*
AAB30
NOMESCO Finland
Evacuation of spontaneous intracranial haematoma
26.8
6.2
8
*
G91.3
ICD-10 Finland
Post-traumatic hydrocephalus, unspecified
26.8
6.2
8
*
F33.3
ICD-10 Finland
Recurrent depressive disorder, current episode severe with psychotic symptoms
26.8
6.2
8
*
GBB03
NOMESCO Finland
Percutaneous tracheostomy
26.8
6.2
8
*
F21
ICD-10 Finland
Schizotypal disorder
7.1
6.2
14
20
B01AC04
ATC
clopidogrel; oral
1.6
6.2
149
956
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
6.2
334
2564
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.0
6.2
32
107
M79.6
ICD-10 Finland
Pain in limb
1.4
6.2
324
2473
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.2
6.1
29
91
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.9
6.1
35
123
W17
ICD-10 Finland
Other fall from one level to another
2.3
6.1
50
218
SPAT1293
SPAT
Other function in accordance with rehabilitation guidance nomenclature
8.6
6.1
12
14
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
8.6
6.1
12
14
F32.1
ICD-10 Finland
Moderate depressive episode
2.5
6.1
46
190
XKC03
NOMESCO Finland
Water cystometry
3.1
6.1
31
103
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
3.1
6.1
31
103
J01.1
ICD-10 Finland
Acute frontal sinusitis
4.4
6.0
20
46
N06AG02
ATC
moclobemide; oral
2.4
6.0
47
200
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
4.2
6.0
21
51
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3009466) Valproate [Moles/volume] in Serum or Plasma
294
91
40.56
307.65
5.1
6.7
umol/l
372.0
374.4
0.05
269
79
(3023183) Ammonium ion [Moles/volume] in Plasma
258
217
14.33
263.74
3.8
3.0
umol/l
33.5
39.5
0.68
225
182
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
165
71
26.19
232.94
1.7
1.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
777
2705
5.17
207.44
5.3
2.0
u/l
298.0
227.8
0.65
756
2525
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
206
207
11.48
185.93
1.5
1.7
mg/l
636.7
520.0
0.74
200
196
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
96
13
79.17
179.40
4.0
2.3
umol/l
32.2
32.4
—
73
8
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
191
185
11.79
176.55
1.5
1.8
mmol/l
4.1
3.7
2.81
180
175
(3044290) Cell count panel - Cerebral spinal fluid
174
172
11.40
158.24
1.8
1.9
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
112
52
23.31
152.59
1.3
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
103
47
23.56
141.18
1.2
1.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
165
185
9.97
136.71
1.9
1.9
e6/l
1165.5
612.0
0.36
146
145
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
165
185
9.97
136.71
1.8
1.8
e6/l
24.8
58.0
0.48
138
142
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
90
32
29.97
134.95
2.0
1.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
218
347
7.25
134.70
2.8
2.3
ug/l
539.0
346.9
0.50
202
329
(3012095) Magnesium [Moles/volume] in Serum or Plasma
467
1613
3.83
113.72
4.8
3.6
mmol/l
0.8
0.8
0.86
443
1509
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
108
92
12.63
107.62
1.2
1.0
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
432
1469
3.80
106.85
2.6
2.3
s
29.1
30.1
2.12
410
1419
(3023368) Bacteria identified in Blood by Culture
643
2891
3.25
100.79
5.9
4.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
65
23
29.58
97.28
1.1
1.0
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
88
64
14.60
96.19
2.7
1.4
promille
0.5
1.3
3.27
71
49
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
62
20
32.38
95.51
1.1
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
62
20
32.38
95.51
1.1
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
64
23
29.10
95.27
1.1
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
62
22
29.43
92.66
1.1
1.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
350
1133
3.78
91.70
13.5
7.7
mmol/l
1.4
1.0
0.80
272
889
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
350
1134
3.78
91.57
13.3
7.7
kpa
5.1
5.1
0.52
329
1084
(3027801) Oxygen [Partial pressure] in Arterial blood
349
1134
3.76
90.86
13.3
7.7
kpa
13.1
12.5
1.17
328
1086
(3003458) Phosphate [Moles/volume] in Serum or Plasma
395
1396
3.54
90.43
6.4
6.1
mmol/l
1.1
1.1
0.00
366
1291
(3016018) Differential panel - Cerebral spinal fluid
97
97
10.66
86.70
1.9
2.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
63
32
20.56
82.12
1.3
1.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
306
1017
3.57
75.86
14.8
8.1
%
96.2
95.6
0.95
289
986
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
63
38
17.31
75.81
1.2
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
411
1638
3.13
75.65
2.3
1.8
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
284
902
3.69
75.40
8.1
8.1
mmol/l
7.8
10.2
6.46
265
856
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
801
4549
2.76
75.35
12.9
6.3
mmol/l
1.2
1.2
10.39
752
4135
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
55
25
22.85
75.00
1.2
1.0
ng/l
75.5
304.2
—
14
5
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
858
5055
2.78
74.88
13.2
6.8
mmol/l
1.2
1.2
9.94
735
4291
(3019060) Gas panel - Arterial blood
223
606
4.18
73.85
15.5
4.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
284
938
3.54
70.73
15.4
8.1
g/l
121.5
121.1
0.11
268
904
(3003181) Sodium [Moles/volume] in Urine
105
156
7.19
68.15
1.6
1.4
mmol/l
70.8
71.3
0.03
87
127
(3008152) Bicarbonate [Moles/volume] in Arterial blood
211
593
4.01
66.42
20.4
6.2
mmol/l
25.0
24.4
1.66
193
557
(3032080) INR in Blood by Coagulation assay
725
4103
2.58
65.79
11.0
9.2
inr
1.2
1.3
2.56
232
1181
(3013826) Glucose [Moles/volume] in Serum or Plasma
932
6038
2.60
62.07
11.5
4.7
mmol/l
6.7
6.7
0.03
891
5620
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
38
10
39.02
61.61
1.2
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
62
53
12.19
61.30
1.1
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
579
3042
2.53
60.16
4.4
3.0
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
741
4393
2.45
58.65
6.6
5.1
g/l
33.1
35.4
15.70
692
4084
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
37
11
34.52
58.02
2.4
1.8
umol/l
18.5
16.3
0.23
37
11
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
42
19
22.75
57.21
1.1
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
69
80
9.02
55.07
1.1
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
41
23
18.33
50.87
1.2
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
636
3706
2.30
49.99
6.1
3.3
ng/l
40.1
57.7
0.80
516
2541
(3047181) Lactate [Moles/volume] in Blood
121
277
4.68
49.44
20.5
5.3
mmol/l
1.4
1.3
0.47
101
240
(3036481) Cortisol [Moles/volume] in Serum or Plasma
227
809
3.15
48.85
2.3
2.1
nmol/l
360.1
383.6
1.01
209
740
(1616796) Gas panel - Central venous blood
101
203
5.28
48.07
6.0
3.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
286
1169
2.81
48.05
2.2
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
286
1182
2.78
46.96
2.2
1.7
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
146
401
3.95
46.93
4.1
1.8
ug/l
2.6
1.6
0.44
122
352
(3009343) pH of Capillary blood
183
594
3.39
45.80
6.0
4.8
ph
7.4
7.4
0.55
32
76
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
178
573
3.41
45.12
6.0
4.9
mmol/l
2.2
1.9
0.45
129
410
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
799
5263
2.20
44.81
8.9
6.4
umol/l
10.1
12.1
4.87
756
4990
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
183
605
3.33
44.42
6.0
4.8
kpa
5.3
5.1
2.34
171
560
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
170
537
3.46
44.37
19.4
10.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
538
3038
2.25
44.33
3.7
2.5
u/l
54.6
57.4
0.50
510
2800
(3014111) Lactate [Moles/volume] in Serum or Plasma
240
938
2.88
43.56
7.7
8.1
mmol/l
1.5
1.4
0.57
225
896
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
69
107
6.73
42.86
1.4
1.6
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
68
104
6.82
42.79
1.4
1.2
mosm/kgh2o
279.7
280.6
0.09
57
75
(3002032) Base excess in Venous blood by calculation
257
1052
2.76
42.69
6.0
4.7
mmol/l
1.5
1.8
0.62
209
826
(3039000) Anion gap in Blood
92
199
4.88
40.16
25.1
6.0
mmol/l
11.1
11.3
0.33
79
178
(3021447) Carbon dioxide [Partial pressure] in Venous blood
253
1058
2.70
40.14
6.1
4.6
kpa
5.8
5.8
0.07
243
1026
(3018572) Chloride [Moles/volume] in Blood
92
200
4.85
39.92
25.1
5.9
mmol/l
104.5
105.2
0.42
79
179
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
195
714
3.01
39.65
2.0
1.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
60
90
6.92
38.42
2.5
2.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
553
3298
2.11
38.40
5.0
3.2
u/l
31.7
39.8
0.95
516
3144
(3018418) pH of Serum or Plasma
513
2974
2.14
38.37
5.6
4.0
ph
7.4
7.4
0.59
121
551
(3014576) Chloride [Moles/volume] in Serum or Plasma
290
1323
2.50
38.32
10.3
7.2
mmol/l
103.8
104.5
1.29
281
1292
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
138
419
3.54
38.13
17.6
4.2
%
1.8
1.6
1.45
125
394
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
27
11
25.01
38.03
1.1
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
134
410
3.51
36.56
18.5
4.3
%
1.0
0.9
2.56
121
385
(3010421) pH of Blood
101
254
4.21
36.47
6.9
3.8
ph
7.4
7.4
0.35
82
205
(3007853) Bacteria identified in Skin by Aerobe culture
261
1161
2.53
36.24
2.0
1.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
64
110
6.05
35.92
2.3
2.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
177
650
2.97
35.65
2.0
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
362
1873
2.25
35.63
1.9
1.8
nmol/l
1228.2
1177.5
0.45
288
1429
(3020891) Body temperature
122
364
3.57
34.56
11.7
4.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
44
53
8.54
33.98
1.9
2.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
105
286
3.89
33.97
1.3
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
224
956
2.60
33.75
9.4
9.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
87
207
4.41
33.74
7.3
4.1
mmol/l
3.0
2.5
0.66
63
132
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
39
7
57.22
33.37
1.2
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
118
354
3.55
33.13
2.3
1.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
38
40
9.74
32.49
1.2
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
33
29
11.63
31.88
1.9
18.7
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
921
6877
1.98
31.51
7.0
4.2
e6/l
2331.6
2268.0
0.01
13
102
(42870588) Differential panel, method unspecified - Blood
555
3501
1.97
31.45
6.9
6.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
72
158
4.75
30.85
2.0
2.2
—
—
—
0
0
(4198724)
35
36
9.94
30.41
1.5
1.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
56
100
5.79
30.21
1.4
1.7
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
36
9
41.04
29.07
1.2
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
80
203
4.12
28.50
3.4
2.4
%
17.1
16.1
1.11
42
109
(3024354) Oxygen [Partial pressure] in Venous blood
205
911
2.46
28.09
5.9
4.0
kpa
5.2
4.6
1.46
197
884
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
144
543
2.84
27.43
8.1
10.8
mmol/l
23.8
24.3
0.90
136
508
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
189
818
2.51
27.37
2.9
2.3
ug/l
8.3
7.7
0.08
160
720
(3026782) Osmolality of Urine
378
2183
2.00
26.86
3.6
2.8
mosm/kgh2o
517.6
559.5
2.79
337
1836
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
63
139
4.70
26.81
1.1
1.1
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
160
650
2.65
26.37
5.9
3.5
g/l
125.5
127.8
0.56
155
634
(3006315) Basophils [#/volume] in Blood
722
5171
1.81
25.95
7.3
5.9
e9/l
0.0
0.0
0.84
634
4428
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
42
66
6.53
25.72
1.3
1.1
mg/l
40.3
45.8
0.26
32
53
(3013115) Eosinophils [#/volume] in Blood
739
5353
1.80
25.35
7.8
6.3
e9/l
0.2
0.2
1.16
658
4670
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
241
1200
2.22
25.23
2.4
1.7
%
1.9
1.5
6.36
209
1045
(3022217) INR in Platelet poor plasma by Coagulation assay
259
1328
2.16
25.19
22.2
25.9
inr
1.3
1.4
0.22
48
167
(3043409) Potassium [Moles/volume] in Arterial blood
95
297
3.36
24.95
11.2
3.7
mmol/l
3.8
3.9
1.02
89
272
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
40
62
6.61
24.81
1.2
1.0
mg/l
281.6
278.6
0.02
34
56
(3019198) Lymphocytes [#/volume] in Blood
733
5321
1.79
24.74
7.4
6.0
e9/l
1.7
1.9
2.60
651
4658
(3001604) Monocytes [#/volume] in Blood
715
5158
1.78
24.60
7.3
5.9
e9/l
0.6
0.6
1.91
634
4415
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
21
13
16.38
24.59
1.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
21
13
16.38
24.59
1.0
1.0
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
425
2620
1.89
24.54
6.3
4.1
%
85.8
88.0
1.02
414
2561
(3015235) Bicarbonate [Moles/volume] in Capillary blood
85
252
3.53
24.24
3.7
3.3
mmol/l
24.6
24.9
0.22
77
220
(3027273) Bicarbonate [Moles/volume] in Venous blood
132
507
2.77
24.23
5.6
3.2
mmol/l
24.8
25.1
0.45
127
488
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
40
64
6.40
24.07
1.1
1.0
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
106
364
3.07
23.83
7.3
5.8
mmol/l
25.3
24.8
1.03
100
342
(3022096) Basophils/100 leukocytes in Blood
667
4760
1.76
23.43
7.4
6.2
%
0.6
0.7
2.35
629
4438
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
109
385
2.98
23.32
2.5
1.8
—
—
—
0
0
(3022313) Gas panel - Capillary blood
116
425
2.88
23.24
6.5
5.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
681
4903
1.75
23.08
7.4
6.2
%
2.5
2.8
2.98
644
4563
(3019069) Monocytes/100 leukocytes in Blood
683
4935
1.74
22.74
7.7
6.4
%
9.0
8.7
0.88
644
4618
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
56
129
4.48
22.61
7.5
5.9
mg/l
12.1
11.4
0.31
49
119
(3015377) Calcium [Moles/volume] in Serum or Plasma
509
3393
1.78
22.37
3.4
3.6
mmol/l
2.3
2.4
3.19
433
2979
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
334
1968
1.91
21.78
5.6
3.6
ng/l
264.3
527.7
1.34
261
1579
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
62
161
3.98
21.41
1.4
1.5
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
18
11
16.56
21.14
1.2
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
497
3335
1.76
21.07
3.4
2.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
80
250
3.33
21.02
1.5
1.6
—
—
—
0
0
(4027681)
34
53
6.55
20.97
1.4
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
690
5084
1.70
20.72
7.5
6.2
%
25.4
27.9
6.74
652
4746
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
554
3852
1.72
20.57
4.4
3.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
135
571
2.51
20.36
6.1
5.8
mmol/l
23.8
23.9
0.10
121
530
(3036489) Thrombin time
98
353
2.91
20.23
2.7
2.7
s
22.3
21.6
0.23
87
322
(3028626) Oxygen [Partial pressure] in Capillary blood
92
321
3.00
20.10
7.6
4.6
kpa
8.5
8.6
0.15
86
297
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
201
1015
2.14
20.05
2.9
2.4
g/l
0.2
0.2
0.60
190
951
(1001926) Buprenorphine [Presence] in Urine by Screen method
87
297
3.06
19.74
2.1
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
261
1460
1.97
19.66
2.7
2.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
979
7986
1.74
19.64
10.5
7.3
u/l
85.5
80.8
2.02
937
7469
(3037467) Urinalysis macro (dipstick) panel - Urine
906
7246
1.70
19.43
6.5
4.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
26
33
8.01
19.19
1.5
1.5
umol/l
185.9
59.8
—
8
19
(3018010) Neutrophils/100 leukocytes in Blood
671
4997
1.65
18.66
7.2
6.0
%
58.8
57.1
2.73
638
4680
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
857
6792
1.67
18.66
5.7
2.9
u/l
77.6
49.6
9.48
812
6317
(3013650) Neutrophils [#/volume] in Blood by Automated count
781
6059
1.65
18.36
11.8
9.4
e9/l
4.4
4.1
1.65
703
5262
(3000850) Epithelial cells [#/volume] in Urine
356
2259
1.77
17.81
3.3
2.6
e6/l
7.7
5.6
1.21
323
1981
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
27
40
6.86
17.45
1.2
1.2
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
21
5
42.55
17.30
1.1
1.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
72
243
3.07
16.68
1.6
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
651
4910
1.61
16.51
5.7
3.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
134
620
2.28
16.48
2.0
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
91
353
2.69
16.34
2.1
1.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
470
3295
1.64
15.94
4.3
3.3
e6/l
71.9
88.8
0.19
396
2554
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
382
2539
1.69
15.92
3.5
2.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
20
23
8.81
15.92
1.2
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
50
138
3.72
15.88
1.4
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
46
121
3.90
15.64
1.4
1.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
248
1464
1.84
15.58
2.9
2.5
g/l
2.3
2.3
0.36
226
1361
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
89
350
2.65
15.56
4.3
3.2
u/ml
0.4
0.4
0.50
65
192
(3000764) Benzodiazepines [Presence] in Urine
94
381
2.57
15.46
2.0
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
94
384
2.55
15.22
2.0
1.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
76
279
2.82
15.17
1.1
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
94
386
2.54
15.05
2.0
1.8
—
—
—
0
0
(3019225) pH of Specimen
173
916
2.01
15.03
5.1
4.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
26
44
6.00
14.81
1.1
1.0
u/l
1.0
1.1
0.58
12
26
(40761535) Cells panel - Urine sediment
155
795
2.07
14.68
4.3
3.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
18
20
9.10
14.68
1.2
1.3
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
26
45
5.87
14.49
1.1
1.1
miu/ml
1814.2
1467.1
0.70
26
45
(3006184) Hemoglobin [Mass/volume] in Capillary blood
63
214
3.03
14.45
3.4
2.3
g/l
134.0
130.1
0.57
53
166
(3021901) Oxygen saturation in Capillary blood
59
193
3.15
14.43
3.8
2.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
386
2631
1.64
14.38
2.4
2.2
mg/l
3.0
2.9
0.36
331
2239
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
901
10386
0.63
14.27
4.2
4.0
mmol/l
1.4
1.5
1.72
810
9538
(44806118)
45
125
3.69
14.18
1.4
1.7
—
—
—
0
0
(44790049)
45
125
3.69
14.18
1.4
1.7
—
—
—
0
0
(44790048)
45
125
3.69
14.18
1.4
1.7
—
—
—
0
0
(44790047)
45
125
3.69
14.18
1.4
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
241
3754
0.57
14.11
2.8
2.7
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
15
14
10.82
13.77
1.1
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
256
1586
1.75
13.53
2.9
2.5
umol/l
11.8
12.8
1.33
235
1468
(3005719) IgG [Mass/volume] in Serum or Plasma
145
749
2.04
13.45
2.4
2.7
g/l
9.8
10.5
1.05
131
683
(3027944) Amphetamines [Presence] in Urine
90
382
2.45
13.45
2.0
1.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
392
2720
1.61
13.44
6.0
3.6
estimate
0.0
0.0
0.88
131
897
(3021960) Folate [Moles/volume] in Serum or Plasma
346
2339
1.64
13.15
1.7
1.5
nmol/l
17.9
20.3
2.35
308
1993
(3006653) Thiamine [Moles/volume] in Blood
25
46
5.51
13.08
1.1
1.2
nmol/l
136.6
135.7
0.03
25
46
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
917
10470
0.64
13.00
4.2
4.0
mmol/l
4.5
4.6
4.76
831
9669
(3023520) Reticulocytes [#/volume] in Blood
161
874
1.95
12.97
2.4
2.8
e9/l
69.4
67.9
0.21
124
661
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
543
4086
1.53
12.96
2.3
1.9
pmol/l
91.9
93.0
0.20
332
2161
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
200
1171
1.82
12.76
3.5
3.0
umol/l
6.9
8.2
0.81
165
1029
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
77
312
2.55
12.70
1.8
1.6
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
17
7
24.55
12.47
1.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
17
7
24.55
12.47
1.0
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
944
10675
0.65
12.22
4.6
4.5
mmol/l
2.6
2.8
8.08
856
9784
(3052851) Hemolysis interference index of Serum or Plasma
76
312
2.52
12.20
5.0
3.4
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
16
6
26.94
12.05
1.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
17
8
21.49
12.02
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
69
274
2.60
11.87
3.5
2.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
203
1220
1.78
11.83
2.4
2.8
%
2.0
1.7
2.15
178
1093
(3030467) Casts [#/volume] in Urine by Automated count
415
2994
1.55
11.76
4.3
3.2
e6/l
0.4
0.5
0.80
342
2285
(3024928) Oxygen saturation in Venous blood
62
237
2.69
11.50
5.1
4.6
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
146
799
1.92
11.46
1.9
2.8
g/l
65.9
65.9
0.03
131
727
(3019150) Specific gravity of Urine by Refractometry
325
2231
1.59
11.40
5.9
3.5
kg/l
1.0
1.0
0.09
55
339
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
221
1376
1.72
11.35
3.1
2.6
%
21.3
22.6
0.57
177
1199
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
188
1118
1.79
11.34
5.3
3.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
21
38
5.59
11.19
1.1
1.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
123
640
2.01
11.17
1.6
2.6
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
14
16
8.83
11.13
2.3
1.8
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
12
11
10.99
11.07
1.1
1.6
mmol/l
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
140
2380
0.54
10.70
2.5
3.0
ug/l
0.6
0.8
1.70
96
1570
(3024869) Neuronal Ab [Presence] in Serum
15
20
7.57
10.57
1.0
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
58
224
2.66
10.57
1.3
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
400
2920
1.52
10.54
4.2
3.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
308
2123
1.58
10.52
1.7
1.7
pmol/l
505.8
15658986.6
1.31
247
1769
(3018095) Leukocytes [#/volume] in Urine
497
3800
1.48
10.41
5.2
3.8
e6/l
133.0
125.0
0.05
414
2715
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
881
10003
0.68
10.36
4.1
3.6
mmol/l
1.4
1.3
3.73
800
9137
(3014148) Varicella zoster virus Ab [Titer] in Serum
40
128
3.19
10.20
1.2
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
15
9
16.83
9.88
1.2
1.9
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
144
825
1.83
9.79
5.0
3.5
mmol/l
1.2
1.2
3.87
137
714
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
33
97
3.46
9.63
2.8
2.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
278
1908
1.57
9.59
2.8
3.2
mmol/l
2.4
2.5
0.30
234
1673
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
190
1189
1.69
9.51
13.8
6.9
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
190
1190
1.69
9.48
2.9
4.3
u/l
242.7
257.9
0.60
183
1129
(40758558) Short blood count panel - Blood
362
2640
1.50
9.42
7.7
7.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
31
92
3.42
8.93
1.6
1.3
nmol/l
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
92
469
2.03
8.86
1.6
2.0
g/l
1.5
1.5
0.07
77
407
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
22
52
4.28
8.67
1.4
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
38
131
2.95
8.59
1.4
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
69
320
2.22
8.49
2.7
2.7
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
21
49
4.34
8.41
2.8
2.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
28
81
3.51
8.39
1.3
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
28
81
3.51
8.39
1.3
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
28
81
3.51
8.39
1.3
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
296
2118
1.50
8.33
2.2
1.8
mg/l
1.4
1.3
0.14
242
1632
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
129
752
1.79
8.29
4.4
4.3
ng/l
92.6
91.2
0.05
110
664
(3028026) IgM [Mass/volume] in Serum or Plasma
108
597
1.88
8.23
1.7
1.8
g/l
1.4
1.4
0.04
99
548
(3011412) CD3 cells [#/volume] in Blood
29
87
3.38
8.23
2.3
2.5
e9/l
1.1
1.2
0.18
18
54
(40757373) Influenza virus identified in Isolate
13
20
6.55
8.07
1.2
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
45
177
2.59
7.97
1.3
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
20
47
4.30
7.95
2.8
2.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
380
2879
1.44
7.94
3.2
3.0
ng/l
2379.3
1797.3
0.66
326
2451
(3015736) pH of Urine
495
3930
1.40
7.93
5.0
3.2
—
5.5
—
0
5
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
21
52
4.08
7.81
1.4
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
620
5121
1.38
7.78
5.4
3.4
estimate
0.0
0.0
0.00
137
932
(3028433) Virus identified in Specimen by Culture
15
28
5.40
7.73
1.1
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
41
959
0.41
7.72
1.4
1.7
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
27
81
3.38
7.68
1.2
1.3
pmol/l
395.8
287.6
0.44
19
59
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
46
187
2.51
7.63
1.7
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
45
1008
0.43
7.61
1.5
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
57
258
2.26
7.46
1.4
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
623
5184
1.36
7.32
5.4
3.4
estimate
0.0
0.0
0.00
144
920
(3052592) Norovirus Ag [Presence] in Stool
12
19
6.36
7.25
1.9
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
491
3943
1.38
7.18
6.0
3.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
616
5129
1.36
7.16
6.9
4.7
estimate
0.0
0.0
0.00
147
946
(3011397) Hemoglobin [Presence] in Urine by Test strip
317
2362
1.44
7.15
5.0
3.2
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
11
8
13.85
6.89
1.1
2.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
173
1147
1.58
6.83
1.7
1.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
95
537
1.82
6.78
2.4
3.5
pmol/l
4.1
4.5
4.13
82
477
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
58
276
2.15
6.75
1.2
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
23
68
3.42
6.71
1.9
2.6
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
10
14
7.19
6.70
2.6
2.9
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
20
54
3.74
6.65
1.1
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
508
4143
1.35
6.61
2.5
2.3
nmol/l
70.8
76.6
4.47
451
3715
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
22
628
0.34
6.47
1.5
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
60
295
2.08
6.44
2.1
2.3
u/l
3145.1
2985.6
0.03
16
128
(3051651) Icteric interference index of Serum or Plasma
24
76
3.20
6.31
3.0
3.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
170
1144
1.55
6.29
1.7
1.4
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
9
5
18.10
6.27
1.1
5.0
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1158
12250
0.69
6.08
43.3
19.4
e9/l
7.1
6.7
6.09
1129
11839
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
23
73
3.19
6.03
2.0
2.4
%
6.7
13.4
2.70
11
41
(3026361) Erythrocytes [#/volume] in Blood
1158
12246
0.70
6.01
43.3
19.4
e12/l
4.3
4.5
36.87
1126
11832
(3010503) CD19 cells [#/volume] in Blood
17
44
3.90
5.99
2.7
2.0
e9/l
0.2
0.1
0.15
17
44
(3035941) MCH [Entitic mass]
1158
12245
0.70
5.99
43.1
19.3
pg
30.5
30.3
2.92
1140
12022
(3017181) Myelocytes/100 leukocytes in Blood
133
856
1.61
5.95
4.7
4.3
%
1.2
0.9
1.00
50
258
(3024731) MCV [Entitic volume]
1158
12242
0.70
5.94
43.2
19.3
fl
91.3
90.9
2.40
1140
12020
(3013512) EKG study
364
2858
1.37
5.93
4.8
3.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
38
160
2.41
5.91
1.6
1.6
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1159
12249
0.70
5.90
43.7
19.5
g/l
129.1
135.5
33.01
1140
12028
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
62
319
1.99
5.90
3.0
3.0
%
89.0
88.6
0.04
57
303
(3009214) Lutropin [Units/volume] in Serum or Plasma
53
258
2.10
5.86
1.8
1.6
u/l
10.3
8.7
0.29
39
198
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
27
96
2.85
5.85
1.7
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
17
45
3.81
5.82
1.5
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
17
45
3.81
5.82
1.5
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
17
45
3.81
5.82
1.5
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
17
45
3.81
5.82
1.5
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
250
1847
1.43
5.82
1.7
1.8
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1158
12233
0.70
5.77
43.2
19.4
e9/l
244.9
247.1
0.48
1132
11862
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
133
864
1.60
5.73
3.8
2.7
ng/l
182.0
237.1
0.92
123
789
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
34
138
2.50
5.72
1.6
2.1
—
1330.0
—
0
8
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
48
229
2.13
5.60
5.0
5.1
iu/ml
1011.7
558.6
0.28
12
25
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
20
61
3.31
5.59
1.0
1.0
ng/l
271.7
320.5
0.37
14
38
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
14
33
4.27
5.56
5.9
1.9
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
14
33
4.27
5.56
5.9
1.9
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
27
99
2.76
5.55
1.2
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
25
88
2.87
5.53
1.2
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
41
186
2.24
5.42
1.7
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
30
118
2.58
5.39
1.5
1.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
57
295
1.97
5.36
1.7
1.6
mu/l
464.7
292.3
1.79
48
271
(3017569) Oxygen content in Arterial blood
17
48
3.57
5.33
1.5
3.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
10
18
5.59
5.32
10.1
7.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
173
1213
1.49
5.28
1.4
1.3
titre
333.0
495.5
1.58
37
265
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
32
132
2.46
5.23
1.7
1.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
36
157
2.33
5.22
1.1
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
18
54
3.36
5.17
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
18
54
3.36
5.17
1.0
1.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
237
1775
1.40
5.08
3.9
3.1
e6/l
4.1
2.0
1.77
145
1015
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
28
110
2.58
5.06
1.2
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
16
45
3.58
5.05
1.3
1.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
38
173
2.23
5.00
3.5
3.8
%
0.9
1.3
0.37
26
136
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
19
61
3.14
4.92
1.0
1.0
ng/l
906.2
647.5
1.37
13
36
(3017354) Segmented neutrophils/100 leukocytes in Blood
27
106
2.58
4.90
3.4
4.0
%
61.2
54.3
0.93
16
71
(3020491) Glucose [Moles/volume] in Blood
21
72
2.95
4.88
1.7
2.3
mmol/l
7.1
6.6
0.24
15
48
(40761536) Microorganisms panel - Urine sediment
131
882
1.53
4.85
5.8
3.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
90
554
1.67
4.83
1.4
1.3
u/ml
136.5
231.3
1.08
76
511
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
145
999
1.50
4.82
3.4
2.5
u/l
33.3
39.3
0.52
119
855
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
36
163
2.24
4.81
5.0
3.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
28
113
2.51
4.81
3.4
3.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
518
4386
1.29
4.78
3.3
2.7
ug/l
178.4
138.9
1.45
469
4042
(3025941) Bacteria identified in Stool by Culture
86
525
1.68
4.77
1.5
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
29
120
2.45
4.73
1.1
1.2
u/ml
1.9
2.6
0.44
11
35
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
360
1.81
4.72
1.7
2.6
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
360
1.81
4.72
1.7
2.6
g/l
7.4
7.5
0.13
42
280
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
360
1.81
4.72
1.6
2.6
g/l
4.0
3.8
0.36
40
271
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
946
10210
0.78
4.59
4.7
4.1
mmol/l
6.0
5.9
1.04
845
9254
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
28
116
2.44
4.57
2.5
2.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
25
99
2.55
4.48
1.6
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
25
99
2.55
4.48
1.6
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
25
99
2.55
4.48
1.6
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
857
7753
1.27
4.47
4.5
3.6
pmol/l
14.4
14.8
5.17
782
6988
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
239
1833
1.37
4.41
3.6
2.9
e6/l
1.2
1.0
0.78
148
1070
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
257
3251
0.74
4.38
3.3
4.2
%
20.3
21.4
0.52
120
1594
(4035726)
131
905
1.49
4.31
1.4
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
25
101
2.50
4.31
1.6
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
25
101
2.50
4.31
1.6
1.5
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
60
341
1.79
4.30
1.7
2.6
g/l
3.0
3.3
1.20
42
276
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
18
61
2.98
4.29
1.0
1.0
ng/l
38.0
43.4
0.20
13
38
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
330
4021
0.77
4.28
3.7
4.8
ug/l
4.0
2.9
0.32
292
3612
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
22
84
2.64
4.24
2.0
1.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
14
41
3.44
4.19
1.1
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
18
62
2.93
4.18
1.4
2.7
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
43
222
1.97
4.14
1.6
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
43
222
1.97
4.14
1.6
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
21
491
0.42
4.04
1.5
1.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
7
247
0.28
4.02
1.0
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
24
99
2.45
3.98
1.7
1.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
343
1.75
3.94
1.7
2.6
g/l
10.8
10.2
0.33
46
294
(3030905) Polymorphonuclear cells [#/volume] in Blood
36
178
2.05
3.91
2.5
3.5
e9/l
4.6
4.1
0.85
36
178
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
33
158
2.11
3.90
1.1
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
282
2256
1.31
3.90
6.3
4.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
48
263
1.85
3.89
1.2
1.3
ug/g
254.1
291.1
0.59
24
153
(3007164) IgA [Mass/volume] in Serum or Plasma
250
1967
1.33
3.89
1.5
1.4
g/l
2.5
2.5
0.04
163
1176
(3002179) Metamyelocytes/100 leukocytes in Blood
113
776
1.50
3.85
4.4
4.1
%
0.7
0.6
0.09
32
183
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
65
393
1.69
3.79
1.6
1.9
u/l
40.5
39.4
0.11
59
348
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
52
295
1.79
3.78
1.3
1.6
g/l
1.1
1.2
0.61
43
278
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
66
2.75
3.76
1.5
1.5
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
27
121
2.26
3.75
1.1
1.2
u/ml
2.0
3.2
1.42
11
51
(3037756) Immunofixation for Serum or Plasma
39
203
1.95
3.70
1.2
1.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
111
767
1.49
3.68
4.2
2.8
ml/min/173m2
63.7
64.8
0.08
48
309
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
8
12
6.70
3.67
1.0
1.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
9
16
5.65
3.66
1.2
5.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
26
116
2.26
3.65
4.0
5.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
37
190
1.97
3.65
3.1
3.7
%
62.6
57.8
1.52
37
190
(21494815) CD4 cells/100 lymphocytes in Specimen
22
91
2.44
3.64
2.0
2.4
%
48.4
40.1
—
5
8
(21494814) CD8 cells/100 lymphocytes in Specimen
11
30
3.69
3.64
2.3
1.6
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
11
30
3.69
3.64
2.3
1.6
%
7.4
7.8
0.06
11
30
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
50
285
1.78
3.60
1.3
1.6
g/l
0.2
0.2
1.26
41
271
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
9
17
5.32
3.51
1.0
1.3
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
9
17
5.32
3.51
1.0
1.3
%
95.4
81.1
—
9
17
(3013707) Erythrocyte sedimentation rate by Westergren method
830
7588
1.23
3.50
4.4
3.8
mm/h
15.1
12.4
4.10
771
6960
(3003338) MCHC [Mass/volume]
875
9422
0.81
3.47
39.8
17.2
g/l
333.7
332.8
1.67
864
9319
(3021440) Promyelocytes/100 leukocytes in Blood
115
814
1.45
3.39
5.0
4.4
%
0.1
0.1
0.10
43
234
(3009542) Hematocrit [Volume Fraction] of Blood
947
10104
0.81
3.37
31.6
14.7
%
37.5
39.7
8.35
555
7395
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
13
42
3.11
3.37
1.2
1.2
ratio
1.1
1.1
—
5
15
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
53
314
1.71
3.36
1.9
1.6
iu/ml
0.1
18.5
0.49
14
65
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
30
148
2.05
3.32
1.3
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
38
205
1.88
3.28
2.3
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
15
54
2.80
3.26
1.5
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
15
54
2.80
3.26
1.5
1.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
90
614
1.50
3.21
1.3
1.2
iu/ml
133.0
167.5
0.40
37
226
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
11
33
3.35
3.19
1.0
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
9
20
4.52
3.11
2.3
1.6
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
12
5.86
3.02
1.9
2.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
31
161
1.95
3.01
1.2
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
16
63
2.56
2.96
1.1
1.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
51
311
1.66
2.94
1.4
4.1
mg/l
54.7
74.4
0.43
41
244
(3044927) Protein electrophoresis panel - Urine
20
88
2.29
2.94
1.4
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
10
30
3.35
2.91
1.0
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
857
9172
0.83
2.81
36.4
16.7
%
13.9
13.7
2.61
842
8949
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
22
103
2.15
2.81
2.1
2.2
mg/l
54.8
17.7
—
9
25
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
17
71
2.41
2.80
1.1
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
10
31
3.24
2.77
10.1
5.9
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
15
60
2.52
2.70
1.3
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
359
3081
1.22
2.68
3.4
3.2
mmol/l
7.1
7.6
1.20
293
2580
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
19
4.23
2.68
1.3
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
50
312
1.62
2.67
1.4
4.1
mg/l
40.0
79.3
0.49
40
248
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
189
1508
1.29
2.66
1.7
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
16
67
2.40
2.63
1.7
1.9
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
10
262
0.38
2.61
1.1
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
98
1330
0.72
2.61
1.4
1.4
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
7
15
4.68
2.60
1.0
1.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
43
260
1.67
2.59
1.2
1.2
titre
50.0
81.6
—
5
19
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
21
100
2.12
2.59
1.1
1.1
u/l
51.3
64.2
0.54
15
72
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
11
5.47
2.54
1.8
2.3
—
—
—
0
0
(4062490)
18
81
2.24
2.54
1.3
1.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
10
33
3.04
2.53
10.1
5.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
260
2171
1.24
2.51
1.3
1.3
u/ml
1.8
2.0
0.09
63
539
(3021589) Normoblasts [#/volume] in Blood
533
4775
1.19
2.48
14.4
9.4
e9/l
0.0
0.0
0.93
445
3888
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
8
21
3.82
2.46
1.4
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
30
166
1.82
2.46
1.3
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
18
83
2.18
2.41
1.7
1.6
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
18
83
2.18
2.41
1.3
1.3
g/l
2.3
2.8
0.66
13
61
(3024139) IgG subclass 3 [Mass/volume] in Serum
18
83
2.18
2.41
1.3
1.3
g/l
0.3
0.4
0.49
13
60
(3042631) Mycobacterium sp identified in Specimen
25
131
1.92
2.41
1.4
3.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
217
2614
0.80
2.40
1.6
1.6
mmol/l
1.4
1.3
0.31
181
2212
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
6
12
5.02
2.40
1.5
1.2
ng/l
180.1
111.3
—
6
12
(40760888) Immunoglobulin light chains.free panel - Serum
40
243
1.66
2.39
1.3
4.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
53
346
1.55
2.38
1.7
1.5
iu/l
23.5
26.9
0.25
37
286
(3015171) Extractable nuclear Ab [Units/volume] in Serum
50
322
1.57
2.38
1.1
1.2
u/ml
0.2
1.4
—
5
22
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
17
77
2.22
2.38
2.8
1.9
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
5
8
6.27
2.37
1.2
1.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1125
10772
1.22
2.34
32.0
13.3
mg/l
24.7
25.9
0.70
1021
8318
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
28
155
1.82
2.31
1.3
1.1
iu/ml
24.6
39.0
—
7
32
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
72
1006
0.70
2.29
1.5
1.7
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
11
41
2.70
2.28
1.5
1.6
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
11
41
2.70
2.28
1.5
1.6
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
8
23
3.49
2.27
2.3
3.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
9
29
3.12
2.22
1.3
1.6
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
5
9
5.57
2.21
1.0
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
5
9
5.57
2.21
1.0
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
8
24
3.35
2.18
1.3
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
105
1369
0.75
2.18
1.2
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
102
769
1.35
2.17
5.2
4.5
%
0.1
0.6
0.47
33
196
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
38
235
1.63
2.15
1.3
1.3
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
14
4.30
2.15
1.0
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
943
9917
0.85
2.12
25.7
12.7
ml/min/173m2
86.6
80.8
9.29
820
8059
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
12
49
2.46
2.10
1.0
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
10
37
2.71
2.10
2.9
2.7
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
8
25
3.21
2.09
1.3
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
8
25
3.21
2.09
3.1
2.3
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
49
326
1.52
2.06
6.5
6.5
mg/l
1.7
1.5
0.73
44
300
(3020393) Adenovirus Ag [Presence] in Stool
7
20
3.51
2.05
1.7
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
27
154
1.77
2.05
1.5
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
910
9586
0.86
2.04
6.1
5.3
mmol/mol
39.9
39.5
0.47
826
8829
(36660697) Celiac disease serology panel - Serum
102
778
1.34
2.03
1.2
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
47
311
1.53
2.02
1.5
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
10
38
2.64
2.01
4.1
5.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
92
693
1.35
1.99
4.4
3.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
54
370
1.48
1.98
3.4
4.0
g/l
0.3
0.3
0.06
27
170
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
16
77
2.09
1.97
1.8
2.8
%
47.9
38.8
—
10
24
(4306422)
21
112
1.89
1.96
1.1
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
21
3.34
1.96
1.1
1.7
—
—
—
0
0
(3011648) Oxygen content in Venous blood
18
91
1.99
1.95
3.6
6.8
%
11.4
11.2
0.06
18
91
(3050129) First trimester maternal screen panel - Serum or Plasma
14
282
0.49
1.95
1.4
1.5
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
8
187
0.42
1.93
1.1
1.1
—
2.5
—
0
84
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
33
2.74
1.93
1.7
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
33
2.74
1.93
1.7
1.6
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
43
284
1.53
1.89
1.4
2.6
g/l
0.1
0.0
0.21
35
256
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
34
2.66
1.86
1.7
1.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1146
11059
1.19
1.85
38.5
15.3
mmol/l
138.5
139.6
24.63
1126
10728
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
45
302
1.51
1.84
1.5
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
47
321
1.48
1.78
1.4
2.7
g/l
0.6
1.1
0.63
36
275
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
35
224
1.58
1.77
1.4
1.3
u/ml
193.8
245.5
0.56
20
133
(3014765) Yersinia sp identified in Stool by Organism specific culture
45
306
1.49
1.74
1.5
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
36
233
1.56
1.74
1.6
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
12
244
0.49
1.74
1.1
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
27
429
0.62
1.68
1.3
1.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
23
134
1.73
1.66
1.3
1.4
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
21
120
1.76
1.62
1.3
1.5
nmol/l
0.2
0.4
1.54
15
101
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
43
295
1.47
1.61
1.4
2.5
g/l
36.3
36.9
0.21
31
256
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
14
3.58
1.61
1.4
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
12
56
2.15
1.61
1.2
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
12
56
2.15
1.61
1.8
1.6
—
—
—
0
0
(4094501)
13
248
0.52
1.58
1.0
1.1
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
25
152
1.66
1.57
4.0
2.5
mmol/l
104.7
105.5
0.23
25
152
(3041354) Potassium [Moles/volume] in Venous blood
25
152
1.66
1.57
4.0
2.5
mmol/l
4.1
4.1
0.12
25
152
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
28
176
1.60
1.55
1.2
1.1
—
—
—
0
0
(4268621)
16
85
1.89
1.55
1.9
2.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
12
57
2.11
1.55
1.2
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
15
78
1.93
1.54
2.5
2.4
e6/l
1137.1
711.0
—
8
24
(3023511) Choriogonadotropin [Units/volume] in Urine
28
177
1.59
1.52
1.3
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
9
37
2.44
1.48
1.2
2.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
24
147
1.64
1.48
4.1
2.5
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1144
11094
1.17
1.47
37.5
15.5
mmol/l
4.0
4.0
1.58
1124
10737
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
20
117
1.72
1.45
1.1
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
96
765
1.27
1.45
1.5
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
227
0.52
1.44
1.0
1.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
22
2.73
1.43
2.2
2.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
22
2.73
1.43
1.0
1.2
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
39
270
1.46
1.43
1.4
2.7
g/l
0.0
0.0
0.00
31
244
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
226
0.53
1.42
1.0
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
224
0.53
1.39
1.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
224
0.53
1.39
1.0
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
66
504
1.32
1.37
2.7
2.3
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
39
273
1.44
1.36
1.4
2.6
g/l
0.0
0.0
0.00
31
245
(3006442) Creatine [Moles/volume] in Serum or Plasma
12
61
1.98
1.33
1.6
1.4
—
76.0
—
0
7
(3024891) Influenza virus A+B Ag [Presence] in Specimen
40
284
1.42
1.30
1.4
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
6
24
2.51
1.30
1.0
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
26
169
1.55
1.29
1.8
1.6
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
18
2.78
1.28
10.2
4.6
mmol/l
4.4
7.6
—
5
18
(3013247) Albumin in CSF/Albumin in Serum or Plasma
5
18
2.78
1.28
1.4
1.1
mg/g
7.8
8.2
—
5
18
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
83
1032
0.79
1.27
1.5
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
17
99
1.73
1.27
1.2
1.3
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
6
25
2.41
1.24
1.2
1.6
pmol/l
12.7
14.0
—
6
20
(3048879) Bone marrow aspiration report
6
25
2.41
1.24
1.3
2.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
986
9506
1.12
1.23
5.3
4.2
mu/l
1.9
2.1
0.96
901
8631
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
19
2.64
1.21
1.4
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
5
19
2.64
1.21
1.2
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
12
213
0.56
1.20
1.6
1.3
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
26
2.31
1.18
2.0
1.0
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
19
117
1.63
1.18
1.2
1.4
mmol/l
6.5
6.8
0.15
19
109
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
126
0.47
1.17
1.0
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
33
232
1.43
1.16
1.8
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
15
87
1.73
1.15
1.3
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
15
87
1.73
1.15
1.2
1.3
—
—
—
0
0
(3000492) Spirometry study
76
941
0.80
1.14
1.7
1.4
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
0
36
0.00
1.14
0.0
1.1
—
16.0
—
0
6
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
30
2.34
1.12
1.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
183
0.54
1.12
1.8
1.7
—
—
—
0
0
(3024932) HLA-DR beta [Type]
8
40
2.01
1.12
1.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
13
73
1.79
1.11
2.4
2.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
312
2837
1.13
1.10
5.4
3.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
41
1.96
1.09
2.7
5.0
—
—
—
0
0
(3024471) HLA-A [Type]
8
41
1.96
1.09
1.0
1.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
10
181
0.55
1.09
1.0
1.4
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
10
179
0.56
1.05
1.1
1.2
—
38.9
—
0
15
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
15
90
1.67
1.04
2.8
5.2
u/ml
39.8
56.2
—
5
24
(3005033) Fetal Nuchal fold Thickness US
10
178
0.56
1.03
1.0
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
17
106
1.61
1.03
1.4
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
18
114
1.59
1.02
1.2
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
20
131
1.53
1.00
1.4
1.4
e6/l
201503.3
95583.8
0.34
12
74
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
31
223
1.40
0.99
1.8
1.5
u/ml
60.6
133.7
—
6
31
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
158
0.57
0.98
1.0
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
23
2.18
0.98
1.4
1.3
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
30
0.00
0.97
0.0
6.1
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
30
0.00
0.97
0.0
3.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
308
2825
1.12
0.94
3.3
3.2
mg/l
825.0
207.0
1.06
221
1792
(3048929) Epstein Barr virus Ab [Presence] in Serum
47
365
1.30
0.93
1.5
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
11
184
0.59
0.93
1.0
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
43
331
1.31
0.91
1.4
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
13
78
1.67
0.91
1.5
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
372
3999
0.91
0.91
2.0
2.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
54
429
1.27
0.91
1.6
3.2
u/ml
43.9
77.2
1.01
49
418
(3013139) Helicobacter pylori Ag [Presence] in Stool
50
629
0.79
0.90
1.3
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
159
1793
0.87
0.88
1.5
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
14
87
1.62
0.87
1.4
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
16
103
1.56
0.87
1.1
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
11
64
1.72
0.86
1.1
2.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
11
64
1.72
0.86
1.1
2.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
12
72
1.67
0.85
6.4
3.0
u/ml
22.3
62.4
1.02
12
72
(3044007) Cell count panel - Peritoneal fluid
6
31
1.94
0.84
1.5
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
10
57
1.76
0.83
1.0
1.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
10
166
0.60
0.83
3.1
3.7
u/ml
21.3
43.3
—
10
161
(4010399)
78
654
1.20
0.83
1.3
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
145
1284
1.14
0.80
1.4
1.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
25
0.00
0.79
0.0
6.6
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
8
48
1.67
0.78
1.5
1.7
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
26
0.00
0.78
0.0
1.0
—
3.2
—
0
7
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
13
82
1.59
0.78
1.0
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
21
148
1.43
0.78
1.3
1.7
g/l
0.6
0.9
0.84
16
118
(1002224) Polysomnography panel
33
252
1.32
0.77
1.1
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
323
3005
1.10
0.76
4.2
3.9
mg/mmol
23.7
8.6
1.87
208
1916
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
10
59
1.70
0.76
1.7
1.8
—
—
—
0
0
(3012565) Volume of 24 hour Urine
9
53
1.70
0.75
1.8
2.8
ml
3164.4
1810.4
—
9
46
(3000012) Reticulocyte production index
9
54
1.67
0.74
1.3
1.9
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
16
108
1.49
0.73
1.4
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
18
125
1.45
0.72
1.5
1.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
106
0.56
0.72
1.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
159
0.63
0.72
1.2
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
10
60
1.67
0.72
1.2
1.7
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
6
110
0.54
0.72
1.0
1.0
—
0.4
—
0
26
(3000475) Leukocytes [#/volume] in Synovial fluid
31
238
1.31
0.71
2.3
1.7
e6/l
14468.1
13871.8
0.03
22
172
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
26
1.93
0.70
2.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
26
1.93
0.70
1.0
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
42
1.67
0.68
4.3
2.6
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
42
1.67
0.68
1.0
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1130
11497
0.91
0.68
16.3
9.5
u/l
26.8
26.2
0.45
1100
11057
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
33
258
1.29
0.67
1.8
1.4
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
29
223
1.31
0.66
2.8
2.1
nmol/l
0.8
0.7
0.26
22
190
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
15
214
0.70
0.66
1.5
1.5
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
11
167
0.66
0.66
1.6
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
31
242
1.29
0.64
2.0
1.9
iu/l
3.4
5.2
0.99
11
87
(3045414) Leukocytes [Presence] in Urine
53
442
1.21
0.63
2.0
1.9
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
11
165
0.66
0.63
1.6
1.1
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
12
79
1.52
0.62
1.1
1.0
mg/l
283.2
289.0
0.08
12
70
(3017732) Neutrophils [#/volume] in Blood
76
657
1.17
0.61
4.6
2.7
e9/l
3.7
4.0
0.59
48
523
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
164
0.67
0.61
1.0
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
5
30
1.67
0.61
1.2
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
130
1168
1.12
0.61
2.0
2.6
ug/g
140.3
137.5
0.03
105
938
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
22
0.00
0.59
0.0
1.0
—
54.7
—
0
22
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
20
264
0.75
0.57
1.3
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
20
264
0.75
0.57
1.3
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
27
211
1.29
0.57
1.2
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
8
54
1.48
0.57
1.5
2.4
u/ml
837.0
1434.0
—
8
54
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
11
161
0.68
0.57
1.6
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
694
6726
1.06
0.54
3.4
2.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
96
1069
0.89
0.50
1.4
1.3
—
—
—
0
0
(4024509)
10
69
1.45
0.44
1.0
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
58
508
1.15
0.43
1.1
1.0
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
5
32
1.56
0.42
5.0
4.1
—
37.8
—
0
6
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
57
1.41
0.42
1.4
3.4
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
16
0.00
0.41
0.0
5.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
15
114
1.32
0.40
1.4
1.4
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
8
60
1.34
0.40
5.0
8.0
—
71.8
—
0
19
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
18
0.00
0.40
0.0
5.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
27
223
1.21
0.39
1.7
1.7
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
103
0.68
0.39
1.0
1.1
—
—
—
0
0
(44806420)
5
35
1.43
0.39
1.8
2.5
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
7
105
0.67
0.39
1.0
1.1
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
9
67
1.35
0.38
1.4
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
33
281
1.18
0.36
1.3
1.8
—
—
—
0
0
(4034850)
38
328
1.16
0.36
12.2
9.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
125
1161
1.08
0.35
4.1
4.0
%
33.3
32.6
0.24
86
739
(3019832) Treponema pallidum Ab [Presence] in Serum
102
939
1.09
0.35
1.7
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
318
3059
1.05
0.32
1.5
1.4
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
6
47
1.28
0.32
1.0
1.4
ug/l
5.8
5.8
—
6
40
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
15
119
1.26
0.32
1.1
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
94
1015
0.92
0.31
1.8
2.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
19
158
1.21
0.28
1.5
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1123
11332
0.96
0.27
30.3
12.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
48
433
1.11
0.26
2.0
2.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
28
321
0.87
0.26
1.1
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
744
7317
1.04
0.26
4.3
3.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
13
105
1.24
0.25
1.5
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
106
1122
0.94
0.23
1.9
2.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
17
200
0.85
0.22
2.1
1.7
pmol/l
156.1
222.2
1.90
17
187
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
22
253
0.87
0.22
1.3
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
93
0.75
0.22
1.0
1.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
40
1.25
0.22
1.2
1.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
26
229
1.14
0.21
4.0
3.3
nmol/l
0.7
0.8
1.48
19
179
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
13
107
1.22
0.21
1.1
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
12
0.00
0.21
0.0
3.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
12
98
1.23
0.21
1.3
2.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
8
105
0.76
0.21
2.8
1.9
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
14
0.00
0.20
0.0
1.8
—
7.3
—
0
6
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
52
1.15
0.19
1.0
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
53
1.13
0.18
1.0
1.1
iu/ml
195.2
239.8
—
6
53
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
35
320
1.10
0.17
1.4
1.3
miu/ml
170.6
236.3
0.46
11
141
(3026493) Urate [Moles/volume] in Serum or Plasma
267
2601
1.03
0.17
3.0
2.8
umol/l
343.9
6958.6
9.72
224
2275
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
68
1.18
0.16
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
68
1.18
0.16
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
68
1.18
0.16
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
69
1.16
0.16
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
69
1.16
0.16
1.1
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
59
554
1.07
0.16
1.5
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
70
1.14
0.16
1.1
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
38
410
0.92
0.15
2.3
3.5
u/ml
651.2
3260.5
0.53
32
349
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
140
1449
0.96
0.15
1.2
1.2
u/ml
15.1
16.0
0.05
44
548
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
159
1540
1.04
0.14
1.2
1.2
iu/ml
69.7
35.2
0.78
44
492
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
61
577
1.06
0.14
1.4
2.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
49
461
1.07
0.13
1.4
1.9
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
34
318
1.07
0.11
2.2
1.6
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
23
250
0.92
0.11
3.7
3.4
mg/l
12.9
27.9
3.51
17
163
(3015183) Erythrocyte sedimentation rate
5
48
1.04
0.09
1.2
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
54
1.11
0.09
4.0
7.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
36
341
1.06
0.08
1.4
1.7
—
—
—
0
0
(44813793)
5
61
0.82
0.08
1.0
1.0
—
—
—
0
0
(4146454)
9
88
1.02
0.07
2.4
2.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
105
0.86
0.06
2.6
4.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
41
394
1.04
0.06
1.1
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
41
394
1.04
0.06
1.9
1.9
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
111
1089
1.02
0.05
2.9
4.4
ug/l
10.8
23.9
0.74
89
900
(3005570) Glucose [Moles/volume] in Urine
10
109
0.92
0.04
2.1
1.9
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
25
241
1.04
0.02
2.5
2.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
56
570
0.98
0.02
5.6
3.8
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
23
238
0.97
0.02
2.4
2.5
ug/min
252.0
67.5
0.92
14
140
(4281824)
11
103
1.07
0.02
1.5
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
81
819
0.99
0.01
1.9
2.0
nmol/l
11.0
13.6
2.40
70
738
(1761482) Bacteria [#/volume] in Urine by Culture
32
319
1.00
0.00
8.5
4.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
73
0.96
0.00
1.1
1.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.1
—
38.4
—
0
7
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(4038314)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
35.8
—
0
6
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
1.4
—
0
6
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.1
—
21.5
—
0
7
(3013762) Body weight Measured
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
77
0.91
0.00
2.6
1.3
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
60.6
—
0
7
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.1
—
7.6
—
0
7
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_STATUSEPI and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_STATUSEPI | 5.233 [4.4, 6.23] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.205 |
During the follow-up period (1.1.1998 — 31.12.2019), 2011 out of 4852 females with G6_STATUSEPI died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_STATUSEPI | 5.675 [4.84, 6.66] | < 0.001 |
| Birth year | 0.986 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 2659 out of 5690 males with G6_STATUSEPI died.
Mortality risk
Mortality risk for people of age
years, who have G6_STATUSEPI.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.468% | 1.096% |
| 5 | 2.941% | 5.976% |
| 10 | 7.489% | 14.464% |
| 15 | 14.532% | 25.265% |
| 20 | 23.537% | 40.207% |
Relationships between endpoints
↥Index endpoint: G6_STATUSEPI – Status epilepticus
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data